Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine

NCT01322048 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT01322048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine
Lead sponsor
Vanderbilt University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2016
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, craniocerebral trauma, trauma, nervous system, traumatic brain injury